|
Aug 9
|
3 US Growth Companies With High Insider Ownership
|
|
Jul 22
|
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
|
|
Jun 26
|
Corcept (CORT) Shares Rise 20% in Three Months: Here's Why
|
|
Jun 24
|
Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions
|
|
Jun 19
|
What Makes Corcept Therapeutics (CORT) a Good Investment Bet?
|
|
Jun 14
|
Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?
|
|
Jun 13
|
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
|
|
Jun 11
|
Insider-Owned Growth Companies To Watch On US Exchanges In June 2024
|
|
Jun 3
|
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
|
|
May 31
|
Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?
|
|
May 31
|
Insider Sale: Chief Development Officer William Guyer Sells 30,000 Shares of Corcept ...
|
|
May 29
|
Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
|
|
May 28
|
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
|
|
May 13
|
3 High Insider Ownership US Growth Companies With Earnings Growth Up To 70%
|
|
May 13
|
Pipeline Moves: Phase III completion for Corcept’s relaorilant
|
|
May 3
|
Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations
|
|
May 2
|
Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
|
|
May 2
|
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Q1 2024 Corcept Therapeutics Inc Earnings Call
|
|
May 2
|
Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
|